
Broad-Based Technical Strength Lifts Neuland Laboratories Ltd to 52-Week High of Rs 22499.95
2026-08-07 12:35:11Surging past its previous peaks, Neuland Laboratories Ltd touched an all-time high of Rs 22,499.95 on 7 Aug 2026, marking a remarkable 74.61% gain over the past year. This rally is underpinned by a confluence of strong technical indicators and sustained price momentum, even as the broader Sensex trades lower.
Read full news article
Neuland Laboratories Ltd is Rated Buy
2026-08-07 10:10:03Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news articleAre Neuland Laboratories Ltd latest results good or bad?
2026-08-06 19:21:15Neuland Laboratories Ltd's latest financial results for Q1 FY27 reflect a complex operational landscape. The company reported net sales of ₹641.58 crores, marking a significant year-on-year growth of 119.16% from a low base in Q1 FY26. However, this growth is tempered by a sequential decline of 17.35% from the previous quarter, indicating volatility in revenue generation. Net profit for the quarter stood at ₹147.67 crores, which represents an impressive year-on-year increase of 962.37%. Nevertheless, this figure also reflects a decrease of 30.56% compared to Q4 FY26, raising questions about the sustainability of such high profitability levels. The operating margin for Q1 FY27 was reported at 34.74%, a substantial increase from 11.78% in the same quarter last year, but a decline from 39.59% in the prior quarter, suggesting challenges in maintaining margin levels. The company's return on equity (ROE) is no...
Read full news article
Neuland Laboratories Ltd Surges on High-Value Trading and Institutional Interest
2026-08-06 10:00:08Neuland Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 6 August 2026, driven by substantial value turnover and heightened institutional participation. The stock outperformed its sector peers and broader market indices, reflecting renewed investor confidence and robust market dynamics.
Read full news article
Broad-Based Technical Strength Lifts Neuland Laboratories Ltd to 52-Week High of Rs 21850
2026-08-06 09:54:45Surging past its previous peaks, Neuland Laboratories Ltd touched a new 52-week high of Rs 21,850 on 6 Aug 2026, propelled by a confluence of robust technical indicators and sustained price momentum that has captivated market attention.
Read full news article
Neuland Laboratories Ltd Surges 7.95% to Day's High of Rs 21,850 — Outperforms Sector by 6.96 Percentage Points
2026-08-06 09:47:04The Sensex edged up 0.23% on 6 Aug 2026, while Neuland Laboratories Ltd surged 7.95%, reaching an intraday high of Rs 21,850. This 6.96-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift.
Read full news article
Neuland Laboratories Ltd Hits All-Time High of Rs 21,850 as Momentum Builds Across Timeframes
2026-08-06 09:31:31Extending its recent rally, Neuland Laboratories Ltd surged to a fresh all-time high of Rs 21,850 on 6 Aug 2026, outperforming its sector and the broader market with a robust 6.82% gain on the day.
Read full news articleBoard Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026
05-Aug-2026 | Source : BSEUnaudited Financial Results of the Company for the quarter ended June 30 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
05-Aug-2026 | Source : BSEPress Release on the Financial Results of the Company for the quarter ended June 30 2026
Disclosure Under Regulation 30 Of SEBI Listing Regulations
05-Aug-2026 | Source : BSEDisclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guarantee
Corporate Actions
No Upcoming Board Meetings
Neuland Laboratories Ltd has declared 340% dividend, ex-date: 24 Jul 26
No Splits history available
No Bonus history available
Neuland Laboratories Ltd has announced 4:25 rights issue, ex-date: 13 Aug 14








